Clinical Trial Update: IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 study update for IKS03 in advanced B-cell non-Hodgkin lymphomas is currently recruiting across multiple subtypes including diffuse large B-cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• B-cell Non-hodgkin Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• IKS03

Snippet

Sponsor: Iksuda Therapeutics Ltd. | Conditions: B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 | Status: RECRUITING